Donghua Guo

Dr. Donghua Guo

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
JJJiancheng Jiang
Jiancheng Jiang
FWFengfeng Wang
Fengfeng Wang
LWLina Wang
Lina Wang
JXJiawei Xiao
Jiawei Xiao
DGDonghua Guo
Donghua Guo

12 March 2024 in Journal of General Virology
Verified
Journal Article
Open access
WBWenfei Bai
Wenfei Bai
QZQinghe Zhu
Qinghe Zhu
JWJun Wang
Jun Wang
LJLimin Jiang
Limin Jiang
DGDonghua Guo
Donghua Guo
DSDongbo Sun
Dongbo Sun
Porcine epidemic diarrhea virus (PEDV) causes severe diarrhea and even death in piglets, resulting in significant economic losses to the pig industry. Because of the ongoing mutation of PEDV, there might be variations between the vaccine strain and the prevailing strain, causing the vaccine to not offer full protection against different PEDV variant strains. Therefore, it is necessary to develop anti-PEDV drugs to compensate for vaccines. This study confirmed the anti-PEDV effect of licorice extract (Le) in vitro and in vivo. Le inhibited PEDV replication in a dose-dependent manner in vitro. By exploring the effect of Le on the life cycle of PEDV, we found that Le inhibited the attachment, internalization, and replication stages of the virus. In vivo, all five piglets in the PEDV-infected group died within 72 h. In comparison, the Le-treated group had a survival rate of 80 % at the same time, with significant relief of clinical symptoms, pathological damage, and viral loads in the jejunum and ileum. Our results suggested that Le can exert anti-PEDV effects in vitro and in vivo. Le is effective and inexpensive; therefore it has the potential to be developed as a new anti-PEDV drug.

3 June 2015 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
DSDongbo Sun
Dongbo Sun
CLChunqiu Li
Chunqiu Li
CGCheng Gu
Cheng Gu
JCJianfei Chen
Jianfei Chen
YQYongli Qu
Yongli Qu
DGDonghua Guo
Donghua Guo

10 January 2022 in Veterinary Microbiology
Verified
Journal Article
Closed access
XHXianjing He
Xianjing He
KJKai Jiang
Kai Jiang
JXJiawei Xiao
Jiawei Xiao
SLShuai Lian
Shuai Lian
YCYaping Chen
Yaping Chen
DGDonghua Guo
Donghua Guo

6 December 2021 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
JXJiawei Xiao
Jiawei Xiao
JJJiancheng Jiang
Jiancheng Jiang
XHXianjing He
Xianjing He
SZSiyao Zhang
Siyao Zhang
ZWZhihui Wang
Zhihui Wang
DGDonghua Guo
Donghua Guo
We evaluated the efficacy of three vaccine formulations containing different combinations of proteins (43K OMP, leukotoxin recombinant protein PL4 and hemolysin recombinant protein H2) and killed whole cell Fusobacterium necrophorum in preventing liver abscess. Four subcutaneous vaccines were formulated: vaccine 1 (43K OMP), vaccine 2 (PL4 and H2), vaccine 3 (43K OMP, PL4 and H2), and vaccine 4 (killed whole bacterial cell). 43K OMP, PL4, and H2 proteins were produced by using recombinant protein expression. To evaluate vaccine efficacy, we randomly allocated 50 BALB/c female mice to one of five different treatment groups: PBS control group, vaccine 1, vaccine 2, vaccine 3, and vaccine 4. Mice were vaccinated three times, with 14 days between each immunization. After immunization, the mice were challenged with F. necrophorum. The three key findings of this study are as follows: (1) Vaccine 3 has enabled mice to produce higher antibody titer following bacterial challenge, (2) in the liver pathology of mice, the vaccine 3 liver showed the least pathology, and (3) all four vaccines produced high levels of antibodies and cytokines in mice, but the level of vaccine 3 was the highest. Based on our results, it has been demonstrated that a mixture of F. necrophorum 43K OMP, PL4, and H2 proteins inoculated with mice can achieve protection against liver abscess in mice. Our research may therefore provide the basis for the development of a vaccine against F. necrophorum bovine infections.

14 June 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
FWFeng-Feng Wang
Feng-Feng Wang
PZPeng-Yu Zhao
Peng-Yu Zhao
XHXian-Jing He
Xian-Jing He
KJKai Jiang
Kai Jiang
TWTian-Shuo Wang
Tian-Shuo Wang
DGDonghua Guo
Donghua Guo
Fusobacterium necrophorum can cause liver abscess, foot rot in ruminants, and Lemire syndrome in humans, Also, its virulence factors can induce the apoptosis of macrophages and neutrophils. However, the detailed mechanism has not been fully clarified. This study investigated the mechanisms of apoptosis and inflammatory factor production in F. necrophorum–induced neutrophils and macrophages (RAW246.7). After infection of macrophages with F. necrophorum, 5-ethynyl-2’-deoxyuridine labeling assays indicated that F. necrophorum inhibited macrophage proliferation in a time- and dose-dependent manner. Hoechst staining and DNA ladder assays showed significant condensation of the nucleus and fragmentation of genomic DNA in F. necrophorum–infected macrophages, Annexin V (FITC) and propidium iodide (PI) assay confirmed the emergence of apoptosis in the macrophages and sheep neutrophils with F. necrophorum compared with the control. The group with significant apoptosis was subjected to RNA sequencing (RNA-Seq), and the sequencing results revealed 2581 up– and 2907 downregulated genes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis of the differentially expressed genes showed that F. necrophorum drove apoptosis and production of inflammatory factors by activating genes related to the Nuclear Factor-κB (NF-κB) and death receptor pathways. Meanwhile, quantitative reverse transcription PCR and Western blot validation results were consistent with the results of transcriptome sequencing analysis. In conclusion, F. necrophorum induced apoptosis and production of pro-inflammatory factors through the NF-κB and death receptor signaling pathway, providing a theoretical basis for further mechanistic studies on the prevention and control of F. necrophorum disease treatment.